MMCAP International’s CERo Therapeutics Warrants CEROW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-375,000
| Closed | -$4.99K | – | 214 |
|
|
2025
Q3 | $4.99K | Hold |
375,000
| – | – | ﹤0.01% | 169 |
|
|
2025
Q2 | $8.93K | Hold |
375,000
| – | – | ﹤0.01% | 132 |
|
|
2025
Q1 | $5.44K | Hold |
375,000
| – | – | ﹤0.01% | 122 |
|
|
2024
Q4 | $3.11K | Hold |
375,000
| – | – | ﹤0.01% | 136 |
|
|
2024
Q3 | $1.91K | Hold |
375,000
| – | – | ﹤0.01% | 158 |
|
|
2024
Q2 | $7.54K | Hold |
375,000
| – | – | ﹤0.01% | 145 |
|
|
2024
Q1 | $25.6K | Hold |
375,000
| – | – | ﹤0.01% | 105 |
|
|
2023
Q4 | $8.81K | Hold |
375,000
| – | – | ﹤0.01% | 133 |
|
|
2023
Q3 | $26.9K | Hold |
375,000
| – | – | 0.01% | 94 |
|
|
2023
Q2 | $22.9K | Hold |
375,000
| – | – | 0.01% | 121 |
|
|
2023
Q1 | $15K | Hold |
375,000
| – | – | ﹤0.01% | 206 |
|
|
2022
Q4 | $16.2K | Hold |
375,000
| – | – | ﹤0.01% | 281 |
|
|
2022
Q3 | $30K | Hold |
375,000
| – | – | ﹤0.01% | 332 |
|
|
2022
Q2 | $38K | Hold |
375,000
| – | – | ﹤0.01% | 346 |
|
|
2022
Q1 | $82K | Buy |
375,000
+250,000
| +200% | +$92.8K | ﹤0.01% | 396 |
|
|
2021
Q4 | $53K | Buy |
+125,000
| New | +$57.6K | ﹤0.01% | 408 |
|
Other funds holding CEROW
MMCAP International's CEROW Position: Q4 2025 in Review
MMCAP International sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 375,000 shares — an estimated $4.99K sold.
MMCAP International first reported a position in CEROW in Q4 2021 and held it in 16 quarters. The position peaked at $82K in Q1 2022. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.
- MMCAP International reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
- MMCAP International sold 375,000 CERo Therapeutics Warrants shares in Q4 2025, an estimated $4.99K.
- MMCAP International first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 16 quarters.
- MMCAP International's CERo Therapeutics Warrants position peaked at $82K in Q1 2022.
- 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.
Based on MMCAP International's 13F filing for Q4 2025, filed 9 Feb 2026.